These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32349249)

  • 21. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.
    Santos R; Amaral O
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9 technology and its application in haematological disorders.
    Zhang H; McCarty N
    Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9 human gene replacement and phenomic characterization in
    McDiarmid TA; Au V; Loewen AD; Liang J; Mizumoto K; Moerman DG; Rankin CH
    Dis Model Mech; 2018 Nov; 11(12):. PubMed ID: 30361258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system.
    Zhang Y; Qin W; Lu X; Xu J; Huang H; Bai H; Li S; Lin S
    Nat Commun; 2017 Jul; 8(1):118. PubMed ID: 28740134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
    Hohmann S
    Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
    Jensen TI; Axelgaard E; Bak RO
    Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities.
    Schneider N; Sundaresan Y; Gopalakrishnan P; Beryozkin A; Hanany M; Levanon EY; Banin E; Ben-Aroya S; Sharon D
    Prog Retin Eye Res; 2022 Jul; 89():101029. PubMed ID: 34839010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology.
    Guitart JR; Johnson JL; Chien WW
    J Invest Dermatol; 2016 Sep; 136(9):e87-e93. PubMed ID: 27542298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene therapy for retinal dystrophies].
    Charbel Issa P; Groppe M; MacLaren RE
    Ophthalmologe; 2012 Feb; 109(2):121-8. PubMed ID: 22350548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.
    Zhang HX; Zhang Y; Yin H
    Mol Ther; 2019 Apr; 27(4):735-746. PubMed ID: 30803822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.
    Shao M; Xu TR; Chen CS
    Dongwuxue Yanjiu; 2016 Jul; 37(4):191-204. PubMed ID: 27469250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Therapy in Retinal Dystrophies.
    Ziccardi L; Cordeddu V; Gaddini L; Matteucci A; Parravano M; Malchiodi-Albedi F; Varano M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.